How does hepatitis C have antibody to return a responsibility?
summary
Hepatitis C (HCV) is a common infectious disease in China, which can be transmitted through blood, sex, mother to child or other ways. Similar to hepatitis B, hepatitis C may lead to liver cirrhosis and liver cancer; But different from hepatitis B, hepatitis C is a curable disease after regular treatment! Today let me tell you something about hepatitis C antibody?.
How does hepatitis C have antibody to return a responsibility?
First: hepatitis C is a global epidemic disease caused by hepatitis C virus infection. According to the statistics of the World Health Organization, the global hepatitis C virus infection rate is about 2.8% (about 185 million people in the world), resulting in about 350000 deaths every year. Due to the concealment of hepatitis C, most of the infected people do not know that they have been infected with hepatitis C virus. Therefore, the exact global infection rate of hepatitis C virus is still uncertain. According to the data of "guidelines for the prevention and treatment of hepatitis C (updated version in 2015)", the infection rate of hepatitis C virus in the population aged 1-59 in 2006 was 0.43%. With the high-risk groups and high-risk areas, it is estimated that there are about 10 million cases of infection in China.
Second, there is no vaccine to prevent hepatitis C, but general daily contact such as polite kissing, hugging, sneezing, coughing, food, drinking water, sharing tableware and water cup, no skin damage and other contacts without blood exposure generally do not transmit hepatitis C virus. Therefore, we do not need to talk about the color change of hepatitis C.
Third: no matter acute hepatitis C or chronic hepatitis C, there are general fatigue, anorexia, nausea and right rib pain, a few with low fever, mild hepatomegaly, some patients with splenomegaly, a few patients with jaundice. Severe complications such as ascites, upper gastrointestinal bleeding and hepatic encephalopathy may occur if liver cirrhosis or decompensation of liver function develops. But most patients have no obvious symptoms in the early stage (that is, although they have been infected with the virus, they do not feel uncomfortable); Even some fatigue or loss of appetite is rarely considered liver disease. Some patients have developed liver cirrhosis, may not have special discomfort, often in the physical examination or because of other diseases is found.
matters needing attention
Patients with obvious liver fibrosis and cirrhosis after effective antiviral treatment, and make the virus undetectable (commonly known as negative), can significantly reduce the incidence of liver function decompensation and liver cancer. Foreign data show that the overall SVR rate of patients with genotype 1b hepatitis C treated with this regimen is 93% - 99%. However, if the treatment is started only when there is obvious liver fibrosis or cirrhosis, the effective rate will be significantly reduced.
